top of page
Navigating Recurrent Low-Grade Intermediate-Risk
Non-Muscle Invasive Bladder Cancer
Lacey opens up about navigating recurrent LG-IR-NMIBC and her experience in a clinical trial. Visit ZUSDURI.com for Full Prescribing and Patient Information. Sponsored by UroGen Pharma Ltd.
bottom of page